MyFinsight
Home
About
Contact
cue: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, CUE has $31,644K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
31,644
40,707
Total stockholders' equity
13,246
18,159
Total liabilities and stockholders' equity
31,644
40,707
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Total property and
equipment
$3,904K
Foreign withholding tax
receivable
$1,899K
Prepaid expenses and
other current assets
$3,114K
Deposits, current portion
$1,747K
Accounts receivable
$387K
Marketable securities
$6,971K
Cash and cash
equivalents
$11,701K
Other long-term
assets
$96K
Restricted cash
$153K
Deposits
$667K
Operating lease
right-of-use asset
$4,602K
Property and equipment,
net
$307K
Total current assets
$25,819K
Less accumulated
depreciation
$3,597K
Total assets
$31,644K
Total liabilities and
stockholders' equity
$31,644K
Total stockholders'
equity
$13,246K
Total liabilities
$18,398K
Accumulated deficit
-$370,051K
Accumulated other
comprehensive loss
$1K
Additional paid in capital
$383,218K
Other long-term
payable
$190K
Operating lease
liabilities, non-current
$2,684K
Total current
liabilities
$15,524K
Common stock, 0.001 par
value 300,000,000...
$78K
Current portion of
long-term debt, net
$1,458K
Operating lease
liabilities, current
$2,031K
Research and development
contract liability,...
$7,816K
Accrued expenses
$1,871K
Accounts payable
$2,348K
Subscribe for Financial Insights
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE)